If you have COVID‑19, you may be at high-risk for severe symptoms. Talk to your doctor to see if you are eligible for monoclonal antibody treatment, based on your age, the length of your symptoms, and some medical conditions.
Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, they may prevent them from experiencing severe symptoms that lead to hospitalizations.
Montefiore has been offering monoclonal antibody treatment to patients since December 2020 in our Bronx Emergency Departments. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.
There are two monoclonal antibody therapies available now, which have been authorized by the Food and Drug Administration; more may become available in the future:
- Casirivimab and Imdevimab
The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare. The appointment takes about three hours to complete; afterward, patients receive a follow-up phone visit. A few weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.
To qualify, you must have tested positive for COVID-19 recently; have mild to moderate symptoms that are managed without oxygen support; and fall into one of the high-risk categories below. Monoclonal antibody treatment is not for patients who are hospitalized.
You're eligible to be treated with the monoclonal antibody if you are:
65 years of age or older
55 years or older with:
- Heart disease
- OR high blood pressure
- OR COPD/chronic respiratory disease, including asthma.
Any adult with:
- Obesity (a body mass index [BMI] of 35 or higher)
- OR diabetes (Type 1 or Type 2)
- OR chronic kidney disease
- OR a weakened immune system
- OR you're taking medicine that weakens your immune system.
12 to 17 years of age and at least 40 kg (88 pounds) with:
- Obesity (a BMI greater than or equal to 85 percent of patients of the same age and gender)
- OR regularly uses medical technology such as a ventilator or feeding tube
- OR have a developmental condition like cerebral palsy
- OR sickle cell disease
- OR congenital or acquired heart disease
- OR asthma/chronic respiratory problems requiring daily medication for control.
Montefiore Monoclonal Antibody Infusion Suite
1575 Blondell Ave, Bronx, NY 10461
Now our patients have a safe and promising treatment that may stop them from developing severe illness.